IberiaBank’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-6,131
Closed -$331K 262
2018
Q3
$331K Sell
6,131
-3,141
-34% -$161K 0.04% 215
2018
Q2
$453K Sell
9,272
-1,754
-16% -$99.5K 0.08% 176
2018
Q1
$691K Sell
11,026
-22,219
-67% -$1.52M 0.14% 148
2017
Q4
$2.04M Sell
33,245
-22,956
-41% -$1.42M 0.32% 97
2017
Q3
$3.76M Buy
56,201
+5,318
+10% +$376K 0.62% 52
2017
Q2
$3.96M Buy
50,883
+2,285
+5% +$172K 1.18% 26
2017
Q1
$3.96M Buy
48,598
+16,438
+51% +$1.29M 1.25% 26
2016
Q4
$2.31M Buy
32,160
+9,490
+42% +$686K 0.85% 48
2016
Q3
$1.76M Buy
+22,670
New +$1.83M 0.75% 46

Other funds holding CAH

IberiaBank's CAH Position: Q4 2018 in Review

IberiaBank sold out of Cardinal Health (CAH) in Q4 2018, closing a stake of 6,131 shares — an estimated $331K sold.

IberiaBank first reported a position in CAH in Q3 2016 and held it in 9 quarters. The position peaked at $3.96M in Q2 2017. 718 funds tracked by Wall St. Rank hold CAH as of Q4 2018.

  • IberiaBank reported no remaining Cardinal Health position as of Q4 2018 after selling out during the quarter.
  • IberiaBank sold 6,131 Cardinal Health shares in Q4 2018, an estimated $331K.
  • IberiaBank first reported a position in Cardinal Health in Q3 2016 and held it in 9 quarters.
  • IberiaBank's Cardinal Health position peaked at $3.96M in Q2 2017.
  • 718 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2018.

Based on IberiaBank's 13F filing for Q4 2018, filed 29 Jan 2019.